Live Breaking News & Updates on Research At Pharmala Biotech

Stay updated with breaking news from Research at pharmala biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office

Novel Composition of MDMA Enantiomers leading to next-generation MDMA possibilitiesTORONTO, March 27, 2024 PharmAla Biotech Holdings Inc. , a biotechnology company focused on the research,. ....

New South Wales , Nicholas Kadysh , Harpreet Kaur , Nick Kadysh , Trademark Office , Regulation Services Provider , Pharmala Biotech Holdings Inc , Neither The Canadian Securities Exchange , Drug Administration , University Of Sydney , Research At Pharmala Biotech , Novel Composition , Ala Biotech Holdings , Chemical Entity , General Population , Vice President , Novel Chemical Entity , Active Moiety , Data Exclusivity , Social Anxiety , Autism Spectrum Disorder , Orphan Indication , Intellectual Property Ontario , Canadian Securities Exchange ,

PharmAla named an Intellectual Property Ontario Client

PharmAla named an Intellectual Property Ontario Client
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Province Of Ontario , United Kingdom , British Columbia , Harpreet Kaur , Nicholas Kadyshchief Executive Officerpharmala Biotech Holdings Inc , Neither The Canadian Securities Exchange , University Of Windsor , Regulation Services Provider , Research At Pharmala Biotech , Pharmala Biotech Holdings Inc , International Society For Research , Ala Biotech Holdings , Intellectual Property Ontario , International Society , Canadian Securities Exchange ,

PharmAla Data to be Published in ACS Chemical Neuroscience

Scientific Journal Article follows notable IP updates, including publication of key PCT Patent Application, presentation at International Society for Research into Psychedelics ConferenceVANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased that ....

United States , New Orleans , British Columbia , United Kingdom , Harpreet Kaur , Nick Kadysh , Nicholas Kadysh , William Fantegrossi , James Gauld , A Path To Novel Mental Health Therapies , Neither The Canadian Securities Exchange , University Of Waterloo , Pharmala Biotech Holdings Inc , International Society For Research , University Of Arkansas , Regulation Services Provider , Research At Pharmala Biotech , Scientific Journal Article , International Society , Ala Biotech Holdings , Drug Discovery , Structure Activity Relationships , Novel Mental Health , Patent Prosecution Highway , Medical Sciences , Pharmala Biotech ,

USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States

USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , British Columbia , Harpreet Kaur , David Purcell , Nick Kadysh , Regulation Services Provider , Health Canada , Research At Pharmala Biotech , Drug Administration , Pharmala Biotech Holdings Inc , Neither The Canadian Securities Exchange , Prescriber Program , Vitura Health , Nicholas Kadyshchief Executive Officerpharmala Biotech Holdings Inc , Approved Study , Examine Tolerability , Ala Biotech Holdings , Medical Product , Vice President , Authorized Prescriber Program , Joint Venture , Sales Director David Purcell , Psychedelic Science , Canadian Securities Exchange ,

USFDA Approves LaNeo MDMA for Clinical Trial Use in the

Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) PharmAla Biotech. ....

United Kingdom , United States , British Columbia , Harpreet Kaur , Nicholas Kadysh , David Purcell , Nick Kadysh , Health Canada , Drug Administration , Research At Pharmala Biotech , Regulation Services Provider , Neither The Canadian Securities Exchange , Vitura Health , Prescriber Program , Pharmala Biotech Holdings Inc , Approved Study , Examine Tolerability , Ala Biotech Holdings , Medical Product , Vice President , Authorized Prescriber Program , Joint Venture , Sales Director David Purcell , Psychedelic Science , Canadian Securities Exchange , Canadian Stock Exchange Mdma Cn ,